Cargando…

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture

This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) at 24 months of followup. This is a retrospective multicenter interventional comparative case series of intravi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arevalo, J. Fernando, Sanchez, Juan G., Lasave, Andres F., Wu, Lihteh, Maia, Mauricio, Bonafonte, Sergio, Brito, Miguel, Alezzandrini, Arturo A., Restrepo, Natalia, Berrocal, Maria H., Saravia, Mario, Farah, Michel Eid, Fromow-Guerra, Jans, Morales-Canton, Virgilio
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090772/ https://www.ncbi.nlm.nih.gov/pubmed/21584260 http://dx.doi.org/10.1155/2011/584238

Ejemplares similares

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011)

Using intravitreal bevacizumab (Avastin(®)) – Indian Scenario
por: Kumar, Atul, et al.
Publicado: (2017)

Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
por: Lim, Ji Won, et al.
Publicado: (2011)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)

Intravitreal Bevacizumab (Avastin) as an Adjuvant Treatment in Cases of Neovascular Glaucoma
por: Ghanem, Asaad A., et al.
Publicado: (2009)

Impact of Intravitreal Injection of Bevacizumab (Avastin) on Rabbit's Choroid and Retina
por: Karawya, Sherif, et al.
Publicado: (2008)

Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
por: Karimi, Saeed, et al.
Publicado: (2020)

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Acute Bilateral Endophthalmitis Following Bilateral Intravitreal Bevacizumab (Avastin) Injection
por: Tabatabaii, Ali, et al.
Publicado: (2013)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
por: Kumar, Atul, et al.
Publicado: (2007)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
por: Jain, Prashant, et al.
Publicado: (2017)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

A Prospective, Randomized Comparison of Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab (Avastin) in Diffuse Diabetic Macular Edema
por: Shahin, Maha M., et al.
Publicado: (2010)

The effect of intravitreal bevacizumab (Avastin(®)) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Rechtman, Ehud, et al.
Publicado: (2011)

Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas
por: Hrisomalos, Frank N, et al.
Publicado: (2010)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials
por: Qazi, Hammad A.
Publicado: (2012)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells
por: Merz, Patrick R., et al.
Publicado: (2018)

Acute sterile endophthalmitis following intravitreal bevacizumab: case series
por: Orozco-Hernández, Axel, et al.
Publicado: (2014)

Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
por: Arevalo, J. Fernando, et al.
Publicado: (2023)

Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes
por: Adrean, Sean D., et al.
Publicado: (2017)

Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study
por: Rodríguez, Francisco J., et al.
Publicado: (2022)

Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti-VEGF Intravitreal Injections: Results from the Pan-American Collaborative Retina Study (PACORES) Group
por: Velez-Montoya, Raul, et al.
Publicado: (2021)

Intravitreal Avastin for Choroidal Neovascularization Associated with Stargardt-Like Retinal Abnormalities in Pseudoxanthoma Elasticum
por: Querques, Giuseppe, et al.
Publicado: (2010)

Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
por: Zaman, Yawar, et al.
Publicado: (2013)

Outcome of intravitreal Avastin® injections in patients with macular oedema in Uganda: a cohort study
por: Kabunga, Rachel R., et al.
Publicado: (2022)

Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study
por: Wu, Lihteh, et al.
Publicado: (2022)

Proteins from Avastin® (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear
por: Wan, Jia, et al.
Publicado: (2012)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Intralesional Bevacizumab (Avastin(®)) as a Novel Addition to Infantile Hemangioma Management: A Medical Hypothesis
por: Pourazizi, Mohsen, et al.
Publicado: (2017)

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
por: Raghuram, A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_37s06eqnvfbquvp6injb172j9m